Early Detection Research Network

SLC33A1

Aliases:
This biomarker is also known as:
  • SPG42,
  • Solute Carrier Family 33 (Acetyl-CoA Transporter), Member 1,
  • AT1,
  • Acetyl-CoA Transporter 1,
  • AT-1,
  • SLC33A1,
  • CCHLND,
  • ACATN,
  • Acetyl-Coenzyme A Transporter 1,
  • Solute Carrier Family 33 Member 1,
  • Acetyl-Coenzyme A Transporter,
  • Spastic Paraplegia 42 (Autosomal Dominant),

Description…

From NCBI Gene: The protein encoded by this gene is required for the formation of O-acetylated (Ac) gangliosides. The encoded protein is predicted to contain 6 to 10 transmembrane domains, and a leucine zipper motif in transmembrane domain III. Defects in this gene have been reported to cause spastic paraplegia autosomal dominant type 42 (SPG42) in one Chinese family, but not in similar patients of European descent. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Under Review
Type: Protein
HGNC Name: SLC33A1

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.